Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT-002 Capsules in CKD Stage 3–4 Patients With SHPT and Vitamin D Insufficiency
CTR20231727Phase 3Completed
- Sponsor
- OPKO Health
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cinacalcet in secondary hyperparathyroidism (SHPT), chronic kidney disease (CKD), Vitamin D deficiency (VDD), sponsored by OPKO Health. Started Jun 2023; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on CTR20231727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231727.